Texas Yale Capital Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Sell
410
-20
-5% -$9.6K ﹤0.01% 504
2026
Q1
$211K Sell
430
-30
-7% -$16.3K 0.01% 483
2025
Q4
$267K Buy
+460
New +$260K 0.01% 433
2025
Q2
Sell
-610
Closed -$304K 477
2025
Q1
$304K Buy
610
+80
+15% +$43.3K 0.01% 388
2024
Q4
$276K Buy
530
+38
+8% +$20.9K 0.01% 402
2024
Q3
$304K Buy
492
+15
+3% +$8.88K 0.01% 391
2024
Q2
$264K Buy
477
+35
+8% +$20.1K 0.01% 393
2024
Q1
$257K Hold
442
0.01% 397
2023
Q4
$235K Buy
+442
New +$214K 0.01% 394

Other funds holding TMO

Texas Yale Capital Corp's TMO Position: Q2 2026 in Review

Texas Yale Capital Corp reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q2 2026, selling an estimated $9.6K and leaving 410 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Texas Yale Capital Corp first reported a position in TMO in Q4 2023 and has held it in 9 quarters since. The position peaked at $304K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Texas Yale Capital Corp held 410 shares of Thermo Fisher Scientific worth $206K as of Q2 2026.
  • Texas Yale Capital Corp sold 20 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.6K.
  • Thermo Fisher Scientific made up ﹤0.01% of Texas Yale Capital Corp's portfolio in Q2 2026, its #504 holding.
  • Texas Yale Capital Corp first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 9 quarters since.
  • Texas Yale Capital Corp's Thermo Fisher Scientific position peaked at $304K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Texas Yale Capital Corp's 13F filing for Q2 2026, filed 12 Aug 2026.